Call Options

19 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $117 Million - $127 Million
377,700 Added 1034.79%
414,200 $133 Million
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $5.99 Million - $7.28 Million
-22,800 Reduced 38.45%
36,500 $11.4 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $4.62 Million - $5.58 Million
-17,200 Reduced 22.48%
59,300 $16.9 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $13.1 Million - $14.8 Million
51,200 Added 202.37%
76,500 $22 Million
Q3 2023

May 14, 2024

SELL
$218.65 - $271.46 $11.2 Million - $13.9 Million
-51,200 Reduced 66.93%
25,300 $6.8 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $590,355 - $732,942
2,700 Added 11.95%
25,300 $6.8 Million
Q2 2023

May 14, 2024

SELL
$214.27 - $253.37 $2.06 Million - $2.43 Million
-9,600 Reduced 29.81%
22,600 $5.02 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $2.06 Million - $2.43 Million
-9,600 Reduced 29.81%
22,600 $5.02 Million
Q1 2023

May 14, 2024

SELL
$225.79 - $275.2 $35.1 Million - $42.8 Million
-155,500 Reduced 82.84%
32,200 $7.78 Million
Q1 2023

May 11, 2023

SELL
$225.79 - $275.2 $35.1 Million - $42.8 Million
-155,500 Reduced 82.84%
32,200 $7.78 Million
Q4 2022

May 14, 2024

SELL
$229.03 - $291.01 $32.8 Million - $41.7 Million
-143,300 Reduced 43.29%
187,700 $49.3 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $32.8 Million - $41.7 Million
-143,300 Reduced 43.29%
187,700 $49.3 Million
Q3 2022

May 14, 2024

BUY
$224.46 - $253.15 $50.9 Million - $57.4 Million
226,800 Added 217.66%
331,000 $74.6 Million
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $50.9 Million - $57.4 Million
226,800 Added 217.66%
331,000 $74.6 Million
Q2 2022

May 14, 2024

BUY
$230.71 - $256.74 $6.39 Million - $7.11 Million
27,700 Added 36.21%
104,200 $25.4 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $7.01 Million - $7.8 Million
30,400 Added 41.19%
104,200 $25.4 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $6.18 Million - $6.84 Million
28,200 Added 61.84%
73,800 $17.8 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $5.81 Million - $6.65 Million
29,200 Added 178.05%
45,600 $10.3 Million
Q3 2021

Nov 10, 2021

BUY
$212.27 - $248.7 $3.48 Million - $4.08 Million
16,400 New
16,400 $3.49 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.